Tourmaline Bio, Inc. (TRML)
(Delayed Data from NSDQ)
$15.00 USD
-0.25 (-1.64%)
Updated May 16, 2024 04:00 PM ET
After-Market: $15.01 +0.01 (0.07%) 6:32 PM ET
3-Hold of 5 3
D Value A Growth A Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/12/2024
Time: -- |
6/2024 | $-0.68 | -6.25% |
Earnings Summary
For their last quarter, Tourmaline Bio, Inc. (TRML) reported earnings of -$0.55 per share, beating the Zacks Consensus Estimate of $-0.68 per share. This reflects a positive earnings surprise of 19.12%. Look out for TRML's next earnings release expected on August 12, 2024. For the next earning release, we expect the company to report earnings of -$0.68 per share, reflecting a year-over-year increase of 66%.
Earnings History
Price & Consensus
Zacks News for TRML
Here's What Could Help Tourmaline Bio, Inc. (TRML) Maintain Its Recent Price Strength
TRML: What are Zacks experts saying now?
Zacks Private Portfolio Services